Literature DB >> 20547814

Nationwide investigation of extended-spectrum beta-lactamases, metallo-beta-lactamases, and extended-spectrum oxacillinases produced by ceftazidime-resistant Pseudomonas aeruginosa strains in France.

Didier Hocquet1, Patrick Plésiat, Barbara Dehecq, Pierre Mariotte, Daniel Talon, Xavier Bertrand.   

Abstract

A nationwide study aimed to identify the extended-spectrum beta-lactamases (ESBLs), metallo-beta-lactamases (MBLs), and extended-spectrum oxacillinases (ES-OXAs) in a French collection of 140 clinical Pseudomonas aeruginosa isolates highly resistant to ceftazidime. Six ESBLs (PER-1, n=3; SHV-2a, n=2; VEB-1a, n=1), four MBLs (VIM-2, n=3; IMP-18, n=1), and five ES-OXAs (OXA-19, n=4; OXA-28, n=1) were identified in 13 isolates (9.3% of the collection). The prevalence of these enzymes is still low in French clinical P. aeruginosa isolates but deserves to be closely monitored.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20547814      PMCID： PMC2916347          DOI： 10.1128/AAC.01646-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  36 in total

1.  Rapid detection and identification of metallo-beta-lactamase-encoding genes by multiplex real-time PCR assay and melt curve analysis.

Authors:  Rodrigo E Mendes; Katia A Kiyota; Jussimara Monteiro; Mariana Castanheira; Soraya S Andrade; Ana C Gales; Antonio C C Pignatari; Sergio Tufik
Journal:  J Clin Microbiol       Date:  2006-11-08       Impact factor: 5.948

2.  Detection of a new extended-spectrum oxacillinase in Pseudomonas aeruginosa.

Authors:  Damien Fournier; Didier Hocquet; Barbara Dehecq; Pascal Cholley; Patrick Plésiat
Journal:  J Antimicrob Chemother       Date:  2009-12-11       Impact factor: 5.790

3.  Detection of the novel extended-spectrum beta-lactamase OXA-161 from a plasmid-located integron in Pseudomonas aeruginosa clinical isolates from Spain.

Authors:  C Juan; X Mulet; L Zamorano; S Albertí; J L Pérez; A Oliver
Journal:  Antimicrob Agents Chemother       Date:  2009-09-21       Impact factor: 5.191

4.  Emergence of PER and VEB extended-spectrum beta-lactamases in Acinetobacter baumannii in Belgium.

Authors:  Thierry Naas; Pierre Bogaerts; Caroline Bauraing; Yves Degheldre; Youri Glupczynski; Patrice Nordmann
Journal:  J Antimicrob Chemother       Date:  2006-05-02       Impact factor: 5.790

5.  Incidence of class A extended-spectrum beta-lactamases in Champagne-Ardenne (France): a 1 year prospective study.

Authors:  L Brasme; P Nordmann; F Fidel; M F Lartigue; O Bajolet; L Poirel; D Forte; V Vernet-Garnier; J Madoux; J C Reveil; C Alba-Sauviat; I Baudinat; P Bineau; C Bouquigny-Saison; C Eloy; C Lafaurie; D Siméon; J P Verquin; F Noël; C Strady; C De Champs
Journal:  J Antimicrob Chemother       Date:  2007-09-05       Impact factor: 5.790

6.  Molecular epidemiology of clinical Pseudomonas aeruginosa isolates carrying IMP-1 metallo-beta-lactamase gene in a University Hospital in Turkey.

Authors:  Osman Birol Ozgumus; Rahmet Caylan; Ilknur Tosun; Cemal Sandalli; Kemalettin Aydin; Iftihar Koksal
Journal:  Microb Drug Resist       Date:  2007       Impact factor: 3.431

7.  [Emergence of extended-spectrum beta-lactamases in Pseudomonas aeruginosa: about 24 cases at Rouen University Hospital].

Authors:  M David; J-F Lemeland; S Boyer
Journal:  Pathol Biol (Paris)       Date:  2008-10-04

8.  Emergence of extensive-drug-resistant Pseudomonas aeruginosa in a French university hospital.

Authors:  L Vettoretti; N Floret; D Hocquet; B Dehecq; P Plésiat; D Talon; X Bertrand
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-06-07       Impact factor: 3.267

9.  Beta-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres).

Authors:  Véronique Dubois; Corinne Arpin; Virginie Dupart; Aline Scavelli; Laure Coulange; Catherine André; Isabelle Fischer; Frédéric Grobost; Jean-Philippe Brochet; Isabelle Lagrange; Brigitte Dutilh; Jacqueline Jullin; Patrick Noury; Gilberte Larribet; Claudine Quentin
Journal:  J Antimicrob Chemother       Date:  2008-05-08       Impact factor: 5.790

Review 10.  Diversity, epidemiology, and genetics of class D beta-lactamases.

Authors:  Laurent Poirel; Thierry Naas; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2009-08-31       Impact factor: 5.191
View more
  24 in total

1.  Strain-tailored double-disk synergy test detects extended-spectrum oxacillinases in Pseudomonas aeruginosa.

Authors:  Didier Hocquet; Barbara Dehecq; Xavier Bertrand; Patrick Plésiat
Journal:  J Clin Microbiol       Date:  2011-03-30       Impact factor: 5.948

2.  Phenotypic screening of extended-spectrum ß-lactamase and metallo-ß-lactamase in multidrug-resistant Pseudomonas aeruginosa from infected burns.

Authors:  M Vahdani; L Azimi; B Asghari; F Bazmi; A Rastegar Lari
Journal:  Ann Burns Fire Disasters       Date:  2012-06-30

3.  Clonal dissemination of Pseudomonas aeruginosa isolates producing extended-spectrum β-lactamase SHV-2a.

Authors:  Katy Jeannot; Damien Fournier; Emeline Müller; Pascal Cholley; Patrick Plésiat
Journal:  J Clin Microbiol       Date:  2012-12-12       Impact factor: 5.948

4.  Two novel class I integron arrays containing IMP-18 metallo-β-lactamase gene in Pseudomonas aeruginosa clinical isolates from Puerto Rico.

Authors:  T Martínez; G J Vazquez; E E Aquino; R V Goering; I E Robledo
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

Review 5.  Structure and function of OprD protein in Pseudomonas aeruginosa: from antibiotic resistance to novel therapies.

Authors:  Hui Li; Yi-Feng Luo; Bryan J Williams; Timothy S Blackwell; Can-Mao Xie
Journal:  Int J Med Microbiol       Date:  2012-01-05       Impact factor: 3.473

6.  Most multidrug-resistant Pseudomonas aeruginosa isolates from hospitals in eastern France belong to a few clonal types.

Authors:  Pascal Cholley; Michelle Thouverez; Didier Hocquet; Nathalie van der Mee-Marquet; Daniel Talon; Xavier Bertrand
Journal:  J Clin Microbiol       Date:  2011-05-18       Impact factor: 5.948

7.  Pseudomonas aeruginosa in French hospitals between 2001 and 2011: back to susceptibility.

Authors:  C Slekovec; J Robert; D Trystram; J M Delarbre; A Merens; N van der Mee-Marquet; C de Gialluly; Y Costa; J Caillon; D Hocquet; X Bertrand
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-07       Impact factor: 3.267

8.  Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients.

Authors:  Laurence Armand-Lefèvre; Cécile Angebault; François Barbier; Emilie Hamelet; Gilles Defrance; Etienne Ruppé; Régis Bronchard; Raphaël Lepeule; Jean-Christophe Lucet; Assiya El Mniai; Michel Wolff; Philippe Montravers; Patrick Plésiat; Antoine Andremont
Journal:  Antimicrob Agents Chemother       Date:  2013-01-14       Impact factor: 5.191

9.  Mechanisms of Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa: Results of the GERPA Multicenter Study.

Authors:  Damien Fournier; Romain Carrière; Maxime Bour; Emilie Grisot; Pauline Triponney; Cédric Muller; Jérôme Lemoine; Katy Jeannot; Patrick Plésiat
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

10.  Transfer between an Algerian and a French hospital of four multi-drug resistant bacterial strains together via a single patient.

Authors:  Didier Moissenet; Patrick Richard; Maria Granados; Audrey Mérens; Damien Fournier; Marguerite Fines-Guyon; Guillaume Arlet; Hoang Vu-Thien
Journal:  Int J Burns Trauma       Date:  2015-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.